211 related articles for article (PubMed ID: 22975026)
1. Febrile seizures and measles-mumps-rubella-varicella (MMRV) vaccine: what do primary care physicians think?
O'Leary ST; Suh CA; Marin M;
Vaccine; 2012 Nov; 30(48):6731-3. PubMed ID: 22975026
[TBL] [Abstract][Full Text] [Related]
2. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
[TBL] [Abstract][Full Text] [Related]
3. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures.
Klein NP; Fireman B; Yih WK; Lewis E; Kulldorff M; Ray P; Baxter R; Hambidge S; Nordin J; Naleway A; Belongia EA; Lieu T; Baggs J; Weintraub E;
Pediatrics; 2010 Jul; 126(1):e1-8. PubMed ID: 20587679
[TBL] [Abstract][Full Text] [Related]
4. Safety of measles-containing vaccines in 1-year-old children.
Klein NP; Lewis E; Fireman B; Hambidge SJ; Naleway A; Nelson JC; Belongia EA; Yih WK; Nordin JD; Hechter RC; Weintraub E; Baxter R
Pediatrics; 2015 Feb; 135(2):e321-9. PubMed ID: 25560438
[TBL] [Abstract][Full Text] [Related]
5. Policy statement—Prevention of varicella: update of recommendations for use of quadrivalent and monovalent varicella vaccines in children.
Committee on Infectious Diseases
Pediatrics; 2011 Sep; 128(3):630-2. PubMed ID: 21873692
[TBL] [Abstract][Full Text] [Related]
6. Update: recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding administration of combination MMRV vaccine.
;
MMWR Morb Mortal Wkly Rep; 2008 Mar; 57(10):258-60. PubMed ID: 18340332
[TBL] [Abstract][Full Text] [Related]
7. Measles-containing vaccines and febrile seizures in children age 4 to 6 years.
Klein NP; Lewis E; Baxter R; Weintraub E; Glanz J; Naleway A; Jackson LA; Nordin J; Lieu T; Belongia EA; Fireman B
Pediatrics; 2012 May; 129(5):809-14. PubMed ID: 22473362
[TBL] [Abstract][Full Text] [Related]
8. Risk of febrile convulsions after MMRV vaccination in comparison to MMR or MMR+V vaccination.
Schink T; Holstiege J; Kowalzik F; Zepp F; Garbe E
Vaccine; 2014 Feb; 32(6):645-50. PubMed ID: 24374498
[TBL] [Abstract][Full Text] [Related]
9. Combined measles-mumps-rubella-varicella vaccine and febrile convulsions: the risk considered in the broad context.
Casabona G; Berton O; Singh T; Knuf M; Bonanni P
Expert Rev Vaccines; 2023; 22(1):764-776. PubMed ID: 37642012
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine in healthy children from 9 months of age.
Goh P; Lim FS; Han HH; Willems P
Infection; 2007 Oct; 35(5):326-33. PubMed ID: 17710370
[TBL] [Abstract][Full Text] [Related]
11. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
Lieberman JM; Williams WR; Miller JM; Black S; Shinefield H; Henderson F; Marchant CD; Werzberger A; Halperin S; Hartzel J; Klopfer S; Schödel F; Kuter BJ;
Pediatr Infect Dis J; 2006 Jul; 25(7):615-22. PubMed ID: 16804432
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Combination Measles-Mumps-Rubella-Varicella Vaccine Introduction in Australia.
Macartney K; Gidding HF; Trinh L; Wang H; Dey A; Hull B; Orr K; McRae J; Richmond P; Gold M; Crawford N; Kynaston JA; McIntyre P; Wood N;
JAMA Pediatr; 2017 Oct; 171(10):992-998. PubMed ID: 28806450
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.
Schuster V; Otto W; Maurer L; Tcherepnine P; Pfletschinger U; Kindler K; Soemantri P; Walther U; Macholdt U; Douha M; Pierson P; Willems P
Pediatr Infect Dis J; 2008 Aug; 27(8):724-30. PubMed ID: 18600190
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and reactogenicity of tetravalent vaccine for measles, mumps, rubella and varicella (MMRV) in healthy children: a meta-analysis of randomized controlled trials.
Leung JH; Hirai HW; Tsoi KK
Expert Rev Vaccines; 2015; 14(8):1149-57. PubMed ID: 26081133
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
Vesikari T; Baer M; Willems P
Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
[TBL] [Abstract][Full Text] [Related]
16. Vaccines for measles, mumps, rubella, and varicella in children.
Di Pietrantonj C; Rivetti A; Marchione P; Debalini MG; Demicheli V
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD004407. PubMed ID: 32309885
[TBL] [Abstract][Full Text] [Related]
17. Modelling Hospitalisation Ratios for Febrile Convulsions and Severe Varicella Under Combined Measles, Mumps, Rubella, and Varicella (MMRV-Priorix-Tetra™) Compared to Separate MMR + V Vaccination.
Bauchau V; Van Holle L; Cohen C
Drug Saf; 2015 Nov; 38(11):1095-102. PubMed ID: 26251259
[TBL] [Abstract][Full Text] [Related]
18. Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting.
Jacobsen SJ; Ackerson BK; Sy LS; Tran TN; Jones TL; Yao JF; Xie F; Cheetham TC; Saddier P
Vaccine; 2009 Jul; 27(34):4656-61. PubMed ID: 19520201
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.
Knuf M; Habermehl P; Zepp F; Mannhardt W; Kuttnig M; Muttonen P; Prieler A; Maurer H; Bisanz H; Tornieporth N; Descamps D; Willems P
Pediatr Infect Dis J; 2006 Jan; 25(1):12-8. PubMed ID: 16395096
[TBL] [Abstract][Full Text] [Related]
20. Association of the use of MMRV in infants by pediatric infectious disease specialists with that of other affiliated providers.
Ackerson BK; Li BH; Sy LS; Cheetham TC; Jacobsen SJ
Vaccine; 2014 Apr; 32(16):1863-8. PubMed ID: 24508041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]